[go: up one dir, main page]

PE20130237A1 - Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea - Google Patents

Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea

Info

Publication number
PE20130237A1
PE20130237A1 PE2012002221A PE2012002221A PE20130237A1 PE 20130237 A1 PE20130237 A1 PE 20130237A1 PE 2012002221 A PE2012002221 A PE 2012002221A PE 2012002221 A PE2012002221 A PE 2012002221A PE 20130237 A1 PE20130237 A1 PE 20130237A1
Authority
PE
Peru
Prior art keywords
maturation
cosmetic composition
deficit
diseases
topical pharmaceutical
Prior art date
Application number
PE2012002221A
Other languages
English (en)
Inventor
Noemi Sarra-Baldrich
Bertran Silvia Garcia
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42942086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20130237(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of PE20130237A1 publication Critical patent/PE20130237A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: A) GLICERINA; B) NIACINAMIDA; Y C) EXTRACTO GLICOLICO DE FUCUS SERRATUS; EN DONDE LA RELACION EN PESO DE GLICERINA, NIACINAMIDA Y EL EXTRACTO GLICOLICO DE FUCUS SERRATUS ES DE 1.5:1:0.1 A 1.5:1:0.5. DICHA COMPOSICION TOPICA FARMACEUTICA O COSMETICA PRESENTA UN EFECTO SINERGICO DE SUS COMPONENTES SIENDO UTIL EN LA PROMOCION DE LA MADURACION DE LA ENVOLTURA CORNEA DE LOS CORNEOCITOS DEL ESTRATO CORNEO
PE2012002221A 2010-05-27 2011-05-26 Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea PE20130237A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10382147 2010-05-27

Publications (1)

Publication Number Publication Date
PE20130237A1 true PE20130237A1 (es) 2013-03-18

Family

ID=42942086

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012002221A PE20130237A1 (es) 2010-05-27 2011-05-26 Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea

Country Status (12)

Country Link
US (1) US20130071426A1 (es)
EP (1) EP2575745A1 (es)
JP (1) JP2013527190A (es)
CN (1) CN102933192A (es)
BR (1) BR112012029995A2 (es)
CA (1) CA2798811A1 (es)
CL (1) CL2012003279A1 (es)
CO (1) CO6660486A2 (es)
MX (1) MX2012013647A (es)
PE (1) PE20130237A1 (es)
RU (1) RU2012157219A (es)
WO (1) WO2011147933A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
KR102773605B1 (ko) 2011-12-19 2025-02-25 마리 케이 인코포레이티드 피부톤 향상을 위한 식물 추출물의 조합물
JP5986416B2 (ja) * 2012-04-11 2016-09-06 花王株式会社 皮膚外用剤
KR101373714B1 (ko) * 2012-04-26 2014-03-13 엔프라니 주식회사 각화막 형성 촉진용 화장료 조성물
CN109875920B (zh) * 2012-11-15 2022-06-28 巴斯夫公司 含海洋植物的化妆美容组合物
WO2015138237A1 (en) 2014-03-10 2015-09-17 Mary Kay Inc. Skin lightening compositions
IT201800002843A1 (it) * 2018-02-20 2019-08-20 Idi Farm S R L Composizione per l’uso nel trattamento della dermatite seborroica
CN109662938B (zh) * 2019-02-14 2022-02-01 重庆市洲仨科技发展有限公司 一种植物多糖保湿因子及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002265347A (ja) 2001-03-13 2002-09-18 Shiseido Co Ltd コーニファイドエンベロープの成熟を促す化粧料
EP1618867A1 (en) 2004-07-20 2006-01-25 The Procter & Gamble Company Topical compositions comprising a vitamin B3 compound and their use for treating dry skin
JP5679663B2 (ja) * 2007-02-23 2015-03-04 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 海藻抽出物からのフコイダン精製のためのプロセスの方法

Also Published As

Publication number Publication date
EP2575745A1 (en) 2013-04-10
CA2798811A1 (en) 2011-12-01
WO2011147933A1 (en) 2011-12-01
CN102933192A (zh) 2013-02-13
RU2012157219A (ru) 2014-07-10
US20130071426A1 (en) 2013-03-21
BR112012029995A2 (pt) 2016-08-02
MX2012013647A (es) 2013-02-12
JP2013527190A (ja) 2013-06-27
CO6660486A2 (es) 2013-04-30
CL2012003279A1 (es) 2013-03-22

Similar Documents

Publication Publication Date Title
PE20130237A1 (es) Composicion topica farmaceutica o cosmetica util para el tratamiento de enfermedades o condiciones que cursan con un deficit de la maduracion de la envoltura cornea
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
TR201905586T4 (tr) Amorf dapagli̇flozi̇n i̇çeren formülasyonlar
PE20150092A1 (es) Composiciones farmaceuticas que contienen fumarato de dimetilo
MX365835B (es) Uso de akkermansia para tratar trastornos metabolicos.
CL2013003577A1 (es) Uso de una composicion farmaceutica que comprende panobinostat y ruxolitinib en la prevencion y/o tratamiento de neoplasias mieloproliferativas.
BR112016001446A2 (pt) Composições terapêuticas, produto de combinação, uso in vitro de flecainida e flecainida
MX367091B (es) Una composición farmacéutica o cosmética tópica que comprende un extracto de la baya de la fruta milagrosa (synsepalum dulcificum) para usarse en el tratamiento o la prevención de desórdenes en la piel, mebrana mucosa, cabello, articulaciones y uñas.
UY35073A (es) Derivados de pirrolidinona como moduladores de GPR119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados.
DOP2016000226A (es) Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
MX2017014245A (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas.
CL2016000544A1 (es) Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel.
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
CL2018001104A1 (es) Composición para el cuidado de la piel y procedimiento asociado.
CL2011002043A1 (es) Uso de extractos de zanthoxylum bungeanum para preparar composiciones topicas para el tratamiento cosmetico de las arrugas de la piel; metodo de tratamiento cosmetico de las arrugas que comprende la aplicacion topica del extracto.
MX2012001686A (es) Complejo aclarador de la piel, uso del complejo, composicion cosmetica o farmaceutica que comprende el complejo y metodo para su aplicacion.
BR112018012749A2 (pt) composições para higiene pessoal
BR112012029304A2 (pt) copolíme-ros em bloco de polissiloxano e seu uso em formulações cosmeticas
PE20081881A1 (es) Agentes terapeuticos para canceres resistentes a agentes quimioterapicos que incluyen como ingrediente activo un anticuerpo que reconoce hla de clase i y sus usos
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
MX2016013198A (es) Uso del extracto de undaria para reducir los signos de envejecimiento de la piel.
AR097216A1 (es) Composición para el tratamiento contra el envejecimiento de la piel
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
BR112013021244A2 (pt) composição de cuidado com a pele, e, uso de um guar de hdiroxipropila despolimerizado

Legal Events

Date Code Title Description
FD Application declared void or lapsed